{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:11:32Z","timestamp":1786979492663,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/bf03346518","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T08:29:27Z","timestamp":1395908967000},"page":"611-616","source":"Crossref","is-referenced-by-count":33,"title":["Endothelial function and endothelial nitric oxide synthase intron 4a\/b polymorphism in primary hyperparathyroidism"],"prefix":"10.1007","volume":"32","author":[{"given":"A.","family":"Ekmekci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Abaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Colak","family":"Ozbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Agayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Aksakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Oflaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Erginel-Unaltuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Erbil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,2]]},"reference":[{"key":"BF03346518_CR1","first-page":"N68","volume":"17","author":"IL Nilsson","year":"2002","unstructured":"Nilsson IL, Yin L, Lundgren E, Rastad J, Ekbom A. Clinical presentation of primary hyperparathyroidism in Europe-nationwide cohort analysis on mortality from non malignant causes. J Bone Miner Res 2002, 17: N68\u201374.","journal-title":"J Bone Miner Res"},{"key":"BF03346518_CR2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1365-2362.1998.00289.x","volume":"28","author":"G Hedback","year":"1998","unstructured":"Hedback G, Oden A. Increased risk of death from primary hyperparathyroidism-an update. Eur J Cin Invest 1998, 28: 271\u20136.","journal-title":"Eur J Cin Invest"},{"key":"BF03346518_CR3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2362.1995.tb01525.x","volume":"25","author":"G Hedback","year":"1995","unstructured":"Hedback G, Oden A. Clinical evaluation of total serum calcium in primary hyperparathyroidism and the risk of death after surgery. Eur J Clin Invest 1995, 25: 48\u201352.","journal-title":"Eur J Clin Invest"},{"key":"BF03346518_CR4","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.ehj.2004.07.010","volume":"25","author":"P Andersson","year":"2004","unstructured":"Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease-a review. Eur Heart J 2004, 25: 1776\u201387.","journal-title":"Eur Heart J"},{"key":"BF03346518_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1677\/erc.0.0100309","volume":"10","author":"N Torre Garcia de la","year":"2003","unstructured":"Garcia de la Torre N, Wass JAH, Turner HE. Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer 2003, 10: 309\u201322.","journal-title":"Endocr Relat Cancer"},{"key":"BF03346518_CR6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/eje.0.1470453","volume":"147","author":"V Nuzzo","year":"2002","unstructured":"Nuzzo V, Tauchmanova L, Fonderico F, et al. Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol 2002, 147: 453\u20139.","journal-title":"Eur J Endocrinol"},{"key":"BF03346518_CR7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10554-006-9166-8","volume":"23","author":"M Baykan","year":"2007","unstructured":"Baykan M, Erem C, Erdogan T, et al. Impairment of flow mediated vasodilatation of brachial artery in patients with primary hyperparathyroidism. Int J Cardiovasc Imaging 2007, 23: 323\u20138.","journal-title":"Int J Cardiovasc Imaging"},{"key":"BF03346518_CR8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0895-7061(00)00248-X","volume":"13","author":"M Kosch","year":"2000","unstructured":"Kosch M, Hausberg M, Vormbrock K, Kisters K, Rahn KH, Barenbrock M. Studies on flow-mediated vasodilation and intimamedia thickness of the brachial artery in patients with primary hyperparathyroidism. Am J Hypertens 2000, 13: 759\u201364.","journal-title":"Am J Hypertens"},{"key":"BF03346518_CR9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1043-2760(01)00425-8","volume":"12","author":"TA Abdu","year":"2001","unstructured":"Abdu TA, Elhadd T, Pfeifer M, Clayton RN. Endothelial dysfunction in endocrine disease. Trends Endocrinol Metab 2001,12: 257\u201365.","journal-title":"Trends Endocrinol Metab"},{"key":"BF03346518_CR10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0140-6736(92)93147-F","volume":"340","author":"DS Celermajer","year":"1992","unstructured":"Celermajer DS, Sorensen KE, Gooch WM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992, 340: 1111\u20135.","journal-title":"Lancet"},{"key":"BF03346518_CR11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0735-1097(95)00327-4","volume":"26","author":"TJ Anderson","year":"1995","unstructured":"Anderson TJ, Uehata A, Gerhard MD, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995, 26: 1235\u201341.","journal-title":"J Am Coll Cardiol"},{"key":"BF03346518_CR12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1253\/circj.70.49","volume":"70","author":"B Takase","year":"2006","unstructured":"Takase B, Harnabe A, Satomura K, et al. Comparable prognostic value of vasodilator response to acetylcholine in brachial and coronary arteries for predicting long-term cardiovascular events in suspected coronary artery disease. Circ J 2006, 70: 49\u201356.","journal-title":"Circ J"},{"key":"BF03346518_CR13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/bbrc.1998.8267","volume":"245","author":"T Tsukada","year":"1998","unstructured":"Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in human. Biochem Biophys Res Commun 1998, 245: 190\u20133.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF03346518_CR14","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/clinchem\/46.10.1626","volume":"46","author":"Y Yoon","year":"2000","unstructured":"Yoon Y, Song J, Hong SH, Kim JQ. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphism in coronary artery disease. Clin Chem 2000, 46: 1626\u201330.","journal-title":"Clin Chem"},{"key":"BF03346518_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1399-0004.2002.610113.x","volume":"61","author":"N Cine","year":"2002","unstructured":"Cine N, Hatemi AC, Erginel-Unaltuna N. Association of a polymorphism of the ecNOS gene with myocardial infarction in a subgroup of Turkish MI patients. Clin Genet 2002, 61: 66\u20137.","journal-title":"Clin Genet"},{"key":"BF03346518_CR16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0002-9149(97)10806-2","volume":"18","author":"S Ichihara","year":"1998","unstructured":"Ichihara S, Yamada Y, Fujimura T, Nakashima N, Yokota M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol 1998, 18: 83\u20136.","journal-title":"Am J Cardiol"},{"key":"BF03346518_CR17","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s001090000124","volume":"78","author":"A Pulkkinen","year":"2000","unstructured":"Pulkkinen A, Viitanen L, Kareinen A, Lehto S, Vauhkonen I, Laakso M. Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med 2000, 78: 372\u20139.","journal-title":"J Mol Med"},{"key":"BF03346518_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/01.HYP.32.1.3","volume":"32","author":"Y Miyamoto","year":"1998","unstructured":"Miyamoto Y, Saito Y, Kajiyama N, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998, 32: 3\u20138.","journal-title":"Hypertension"},{"key":"BF03346518_CR19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1161\/01.HYP.32.3.521","volume":"32","author":"K Hibi","year":"1998","unstructured":"Hibi K, Ishigami T, Tamura K, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998, 32: 521\u20136.","journal-title":"Hypertension"},{"key":"BF03346518_CR20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/00043798-200108000-00008","volume":"8","author":"B Granath","year":"2001","unstructured":"Granath B, Taylor RR, van Bockxmeer FM, Mamotte CDS. Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population. J Cardiovas Risk 2001, 8: 235\u201341.","journal-title":"J Cardiovas Risk"},{"key":"BF03346518_CR21","first-page":"2149","volume":"81","author":"BG Leifsson","year":"1996","unstructured":"Leifsson BG, Ahren B. Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab 1996, 81: 2149\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03346518_CR22","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0895-4356(97)00104-2","volume":"50","author":"L Lind","year":"1997","unstructured":"Lind L, Skarfors E, Berglund L, Lithell H, Ljunghall S. Serum calcium: a new, independent prospective risk factor for myocardial infarction in middle aged men followed for 18 years. J Clin Epidemiol 1997, 50: 967\u201373.","journal-title":"J Clin Epidemiol"},{"key":"BF03346518_CR23","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1067\/msy.2001.118368","volume":"130","author":"IL Nilsson","year":"2001","unstructured":"Nilsson IL, Rastad J, Johansson K, Lind L. Endothelial vasodilatory function and blood pressure response to local and systemic hypercalcemia. Surgery 2001, 130: 986\u201390.","journal-title":"Surgery"},{"key":"BF03346518_CR24","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1097\/00005344-199800001-00042","volume":"31","author":"B Jiang","year":"1998","unstructured":"Jiang B, Morimoto S, Yang J, Niinoabu T, Fukuo K, Ogihara T. Expression of parathyroid hormone\/parathyroid hormone-related peptide receptor in vascular endothelial cells. J Cardiovasc Pharmacol 1998, 31: S141\u20134.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF03346518_CR25","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/ndt\/gfm269","volume":"22","author":"G Rashid","year":"2007","unstructured":"Rashid G, Bernheim J, Green J, Benchetrit S. Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol Dial Transplant 2007, 22: 2831\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"BF03346518_CR26","doi-asserted-by":"crossref","first-page":"F1215","DOI":"10.1152\/ajprenal.00406.2006","volume":"292","author":"G Rashid","year":"2007","unstructured":"Rashid G, Bernheim J, Green J, Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Renal Physiol 2007, 292: F1215\u20138.","journal-title":"Am J Physiol Renal Physiol"},{"key":"BF03346518_CR27","doi-asserted-by":"crossref","first-page":"E405","DOI":"10.1152\/ajpendo.2001.280.3.E405","volume":"280","author":"MA Mitnick","year":"2001","unstructured":"Mitnick MA, Grey A, Masuiukiewicz U, et al. Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor. Am J Physiol Endocrinol Metab 2001, 280: E405\u201312.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BF03346518_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.metabol.2006.08.019","volume":"56","author":"E Delfini","year":"2007","unstructured":"Delfini E, Petramala L, Caliumi C, et al. Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism 2007, 56: 30\u20136.","journal-title":"Metabolism"},{"key":"BF03346518_CR29","first-page":"168","volume":"15","author":"M Kosch","year":"2000","unstructured":"Kosch M, Hausberg M, Vormbrock K, et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 2000, 15: 168\u201372.","journal-title":"Cardiovasc Res"},{"key":"BF03346518_CR30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00268-001-0285-z","volume":"26","author":"H Vestergaard","year":"2002","unstructured":"Vestergaard H, Ostergaard KL. Normocalcemia and persistent elevated serum concentrations of 1\u201384 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular disease. Word J Surg 2002, 26: 657\u201360.","journal-title":"Word J Surg"},{"key":"BF03346518_CR31","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1067\/msy.2099.101422","volume":"126","author":"IL Nilsson","year":"1999","unstructured":"Nilsson IL, Aberg J, Rastard J, Lind L Endothelial dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery 1999, 126: 1049\u201355.","journal-title":"Surgery"},{"key":"BF03346518_CR32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2796.1991.tb00403.x","volume":"230","author":"L Lind","year":"1991","unstructured":"Lind L, Jacobsson S, Palmer M, Lithell H, Wengle B, Ljunghall S. Cardiovascular risk factors in primary hyperparathyroidism: a 15 year follow-up of operated and unoperated cases. J Intern Med 1991, 230: 29\u201335.","journal-title":"J Intern Med"},{"key":"BF03346518_CR33","first-page":"887","volume":"20","author":"F Lumachi","year":"2006","unstructured":"Lumachi F, Ermani M, Frego M, et al. Intima-media thickness measurement of the carotid artery in patients with primary hyperparathyroidism. A prospective case-control study and long-term follow-up. In Vivo 2006, 20: 887\u201390.","journal-title":"A prospective case-control study and long-term follow-up. In Vivo"},{"key":"BF03346518_CR34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000045957","volume":"88","author":"K Asanuma","year":"2001","unstructured":"Asanuma K, Yokoyama K, Tsukada T, et al. An intron 4 gene polymorphism in endothelial cell nitric oxide synthase might modulate lipid metabolism in nondiabetic patients on hemodialysis. Nephron 2001, 88: 39\u201343.","journal-title":"Nephron"},{"key":"BF03346518_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/08941930601126280","volume":"20","author":"O Basaran","year":"2007","unstructured":"Basaran O, Atac FB, Karakayali F, et al. Endothelial nitric oxide synthase gene intron 4 (VNTR) polymorphism and vascular access graft thrombosis. J Invest Surg 2007, 20: 49\u201353.","journal-title":"J Invest Surg"},{"key":"BF03346518_CR36","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00467-006-0202-7","volume":"21","author":"H Dursun","year":"2006","unstructured":"Dursun H, Noyan A, Maytar S, et al. Endothelial nitric oxide synthase gene intron 4a\/b VNTR polymorphism in children with APS-GN. Pediatr Nephrol 2006, 21: 1661\u20135.","journal-title":"Pediatr Nephrol"},{"key":"BF03346518_CR37","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/01.CIR.0000024409.30143.70","volume":"106","author":"Y Droma","year":"2002","unstructured":"Droma Y, Hanaoka M, Ota M, et al. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation 2002, 106: 826\u201330.","journal-title":"Circulation"},{"key":"BF03346518_CR38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejvs.2004.02.008","volume":"27","author":"C Fatini","year":"2004","unstructured":"Fatini C, Sofi F, Gensini F, et al. Influence of eNOS gene polymorphisms on carotid atherosclerosis. Eur J Vasc Endovasc Surg 2004, 27: 540\u20134.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"BF03346518_CR39","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0272-6386(03)00030-1","volume":"41","author":"Y Asakimori","year":"2003","unstructured":"Asakimori Y, Yorioka N, Tanaka J, Kohno N. Effect of polymorphism of the endothelial nitric oxide synthase and apolipoprotein E genes on carotid atherosclerosis in hemodialysis patients. Am J Kidney Dis 2003, 41: 822\u201332.","journal-title":"Am J Kidney Dis"},{"key":"BF03346518_CR40","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.ATV.0000016248.51577.1F","volume":"22","author":"J Wang","year":"2002","unstructured":"Wang J, Dudley D, Wang XL. Haplotype-specific effects on endothelial NO synthase promoter efficiency. Modifiable by cigarette smoking. Arterioscler Thromb Vasc Biol 2002, 22: e1\u20134.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BF03346518_CR41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2337\/dc06-1697","volume":"30","author":"I Zineh","year":"2007","unstructured":"Zineh I, Beitelshees AL, Haller MJ. NOS3 polymorphism are associated with arterial stiffness in children with type 1 diabetes. Diabetes Care 2007, 30: 689\u201393.","journal-title":"Diabetes Care"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346518.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03346518\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03346518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,16]],"date-time":"2020-08-16T18:29:06Z","timestamp":1597602546000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03346518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["BF03346518"],"URL":"https:\/\/doi.org\/10.1007\/bf03346518","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}